Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study to Evaluate the Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetic Subjects

NCT00698230 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT00698230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00698230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study to Evaluate the Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetic Subjects
Lead sponsor
Incyte Corporation
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2008
Completion date
May 31, 2009
Enrollment
302 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes